Basit öğe kaydını göster

dc.contributor.authorSumen-Secgin, G
dc.contributor.authorEroglu, L
dc.contributor.authorOzek, M
dc.contributor.authorCimsit, M
dc.date.accessioned2021-03-05T12:22:48Z
dc.date.available2021-03-05T12:22:48Z
dc.date.issued2005
dc.identifier.citationSumen-Secgin G., Cimsit M., Ozek M., Eroglu L., "Antidepressant-like effect of hyperbaric oxygen treatment in forced-swimming test in rats", METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, cilt.27, ss.471-474, 2005
dc.identifier.issn0379-0355
dc.identifier.othervv_1032021
dc.identifier.otherav_acdb836b-9890-4c38-985d-dc4e6b68a499
dc.identifier.urihttp://hdl.handle.net/20.500.12627/115344
dc.identifier.urihttps://doi.org/10.1358/mf.2005.27.7.896829
dc.description.abstractThe present study was undertaken to assess the antidepressant-like activity of hyperbaric oxygen (HBO) treatment and also to investigate whether in the forced-swimming test HBO treatment interacts with the antidepressant effects of fluoxetine, a selective serotonin reuptake inhibitor, and imipramine, which is mainly a noradrenaline reuptake inhibitor. HBO treatment (at 2.4 atmospheres absolute [ATA] for 60 min) significantly reduced the immobility time in this test; in other words, it displayed antidepressant-like activity. The coadministration of HBO with fluoxetine (5 mg/kg) or imipramine (5 mg/kg) at their ineffective doses produced greater inhibition of immobility time compared with HBO alone. In conclusion, HBO treatment might be an alternative approach to antidepressant therapy, alone or in combination with antidepressant drugs. (c) 2005 Prous Science. All rights reserved.
dc.language.isoeng
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectSağlık Bilimleri
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.titleAntidepressant-like effect of hyperbaric oxygen treatment in forced-swimming test in rats
dc.typeMakale
dc.relation.journalMETHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
dc.contributor.department, ,
dc.identifier.volume27
dc.identifier.issue7
dc.identifier.startpage471
dc.identifier.endpage474
dc.contributor.firstauthorID175963


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster